Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

A portfolio for jittery investors: 15 Canadian stocks expected to withstand market volatility

researchsnappy by researchsnappy
March 3, 2020
in Investment Research
0
A portfolio for jittery investors: 15 Canadian stocks expected to withstand market volatility
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

What are we looking for?

Canadian stocks that can weather market volatility.

The screen

After last week’s market correction and continuing uncertainty regarding the COVID-19 outbreak and its effects on global health and the economy, it may be tempting for investors to sell their holdings to cash to avoid further decline. It bears remembering, however, that if your portfolio is down but you choose to wait out the storm, you haven’t actually lost any money. Indeed, based on historical evidence, investors will make that loss back should they stay invested over the long term. This is certainly easier said than done. Taking the time to ensure your portfolio has a strong ability to manage market volatility will make staying invested an easier goal to achieve.

Today’s strategy is searching for a portfolio of Canadian stocks that are poised to weather volatile markets, with a focus on downside protection to avoid any severe downward fluctuations.

Story continues below advertisement

This strategy ranks stocks based on five-year beta (measures a company’s sensitivity relative to historical changes in the benchmark – here we use the S&P/TSX Composite Index – low values preferred); industry-relative earnings variability (measures how volatile a company’s earnings are relative to its industry median – low values preferred); long-term debt-to-equity ratio (a measure of liquidity, low values preferred); and five-year total return standard deviation (a measure of risk, low values preferred).

Stocks that qualify must have:

  • Five-year beta of less than one (in trending markets, a stock with beta less than one has historically moved less than the index);
  • Five-year total return standard deviation in the top two-thirds of peers (today this value is 58.1 per cent or less);
  • Long-term debt-to-equity ratio less than 1.1;
  • Industry-relative earnings variability in the top two-thirds of peers (this value today is 1.7 per cent or less);
  • Market capitalization in the top two-thirds of peers (today, this value is $154.8-million or higher).

More about Morningstar

Morningstar Research Inc. provides independent investment research in North America, Europe, Australia and Asia. Its research tool, Morningstar CPMS, provides quantitative North American equity research and portfolio analysis to institutional clients and financial advisers. CPMS data cover more than 95 per cent of the investable North American stock market.

What we found

I used Morningstar CPMS to back-test this strategy from January, 2004, to January, 2020. During this process, a maximum of 15 stocks were purchased. Stocks were sold if their five-year beta rose above 1.2 or if their long-term debt-to-equity ratio rose above 1.3. When sold, the positions were replaced with the highest-ranked stock not already owned in the portfolio.

Over this period, the strategy produced an annualized total return of 11.4 per cent while the S&P/TSX Composite returned 7.5 per cent on the same basis. The strategy outperformed in 86 per cent of down markets (measured as quarters where the S&P/TSX experienced negative returns) compared with the benchmark.

Stocks that qualify for purchase into the strategy today are listed in the accompanying table. As always, investors are encouraged to conduct their own independent research before purchasing any of the investments listed here.

Select Canadian-listed stocks

Rank Company Ticker Morningstar Sector Mkt. Cap. ($ Mil.) 5Y Beta D/E 5Y Ttl. Rtn. Stand. Dev. (%) Industry Rel. Earns. Var. (%) Div. Yld. (%) Recent Price ($) 12M Price Chg. (%)
1 Winpak Ltd. WPK-T Cons. Cyclical 2,858.1 0.0 0.0 21.4 -2.2 0.3 43.97 2.6
2 Richelieu Hardware Ltd. RCH-T Cons. Cyclical 1,545.8 0.7 0.0 22.2 -8.3 1.0 27.47 16.5
3 Boston Pizza Royalties I.F. BPF-UN-T Cons. Cyclical 288.7 0.9 0.0 17.4 -7.0 9.2 13.25 -22.3
4 Acadian Timber Corp. ADN-T Basic Materials 277.0 0.5 0.0 19.9 -5.0 7.0 16.60 -3.2
5 Blackline Safety Corp. BLN-X Technology 334.7 0.0 0.0 47.9 -4.0 0.0 6.98 36.9
6 Firm Capital Mortg. FC-T Fin’l Services 385.1 0.3 0.5 11.1 -9.3 6.9 13.59 3.7
7 Sylogist Ltd. SYZ-X Technology 216.4 0.0 0.0 30.4 -1.8 4.4 9.10 -27.3
8 Timbercreek Financial TF-T Fin’l Services 797.6 0.5 0.2 11.4 -7.6 7.2 9.58 2.5
9 Atrium Mortgage Invst. AI-T Fin’l Services 573.0 0.6 0.3 12.6 -9.2 6.5 13.77 4.0
10 Enghouse Systems Ltd. ENGH-T Technology 2,798.3 0.5 0.0 28.8 -4.0 0.9 50.90 33.6
11 Corby Spirit & Wine Ltd. CSW-A-T Cons. Defensive 438.4 0.6 0.0 17.9 -5.8 5.7 15.40 -17.0
12 Evertz Technologies ET-T Technology 1,267.6 0.0 0.1 21.3 -6.9 4.4 16.53 0.5
13 Metro Inc. MRU-T Cons. Defensive 13,244.9 0.2 0.7 16.5 -9.5 1.7 52.28 5.7
14 InterRent REIT IIP-UN-T Real Estate 2,017.2 0.2 0.5 16.5 -7.5 1.9 16.59 17.6
15 CGI Inc. GIB-A-T Technology 22,666.0 0.6 0.4 18.5 -11.9 0.0 94.31 6.9

Source: Morningstar Research Inc. 

Emily Halverson-Duncan, CFA, is a director, CPMS sales at Morningstar Research Inc.

Story continues below advertisement

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Previous Post

These Tar Heels didn’t wait to graduate UNC to become published authors

Next Post

The Distribution of Colorectal Surgeons in the United States.

Next Post
Predictors and Barriers to Faculty Scholarly Activity in United States Urology Residency Programs.

The Distribution of Colorectal Surgeons in the United States.

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Pa. Republicans reconsider Pitt funding over fetal tissue research, college voucher program

Arthur Pharma Closes Series A Financing Round

YouTube and the Achilles Tendon: An Analysis of Internet Information Reliability and Content Quality

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2022 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2022 researchsnappy.com